NCT07109739 is a NA clinical trial of POWERbreathe K5 in Systolic Hypertension, sponsored by University of Minnesota.

Who is sponsoring NCT07109739?

NCT07109739 is sponsored by University of Minnesota.

What drugs are being tested in NCT07109739?

Interventions in NCT07109739: POWERbreathe K5.

What condition does NCT07109739 study?

NCT07109739 studies Systolic Hypertension, Brachial Artery Flow-mediated Dilation.

Is NCT07109739 still recruiting?

NCT07109739 is currently recruiting now. Last updated 25 November 2025.

Last reviewed 2025-11-25 · How we verify

NCT07109739

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dose-Response Effects of Inspiratory Muscle Strength Training on Blood Pressure and Vascular Function

Recruiting now NA Last updated 25 November 2025

What this trial tests

NA trial testing POWERbreathe K5 in Systolic Hypertension in 144 participants. Currently enrolling.

Timeline

24 October 2025

Primary endpoint
31 March 2027

31 March 2027

Quick facts

Lead sponsor	University of Minnesota
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	144
Start date	24 October 2025
Primary completion	31 March 2027
Estimated completion	31 March 2027
Sites	1 location across United States

Drugs / interventions tested

POWERbreathe K5

Conditions studied

Systolic Hypertension — all drugs for Systolic Hypertension →
Brachial Artery Flow-mediated Dilation — all drugs for Brachial Artery Flow-mediated Dilation →

Sponsor

University of Minnesota

Who can join

18 and older, any sex, with Systolic Hypertension or Brachial Artery Flow-mediated Dilation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will assess the dose-response effects of Inspiratory Muscle Strength Training (IMST) in adults with above-normal systolic blood pressure over a 6-week period.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of Minnesota trials

Trials by the same sponsor.

NCT02421497 — MRI Technical Development and Applications in Kidney Disease · not yet recruiting
NCT04100109 — Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic · NA · withdrawn
NCT05454306 — Anser Clavicle Pin for Surgical Management of Midshaft Clavicle Fractures · NA · withdrawn
NCT03192007 — Multi-Parametric MRI for Renal Transplantation · not yet recruiting
NCT04940533 — Pharmacokinetics of CFTR Modulators in Pregnant Individuals and in Postpartum Breastfeeding Mothers · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07109739 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Minnesota
Last refreshed: 25 November 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07109739.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing